Company: ZVRA
Filing Date: 2025-03-31
Form Type: PREC14A
Source: 0001193125-25-068746
Chunk: 72

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-03-31
Form: PREC14A
Chunk 72
---
 (b) 39,200 shares underlying these options will vest on the earlier of (i) May 13, 2025, or (ii) one day prior to the Annual Meeting, subject to continued service. |

71

The following table provides information with respect to all of our equity compensation plans in effect as of December 31, 2024. Information is included for the 2007 stock incentive plan (the “2007 Plan”), the 2014 Plan, the 2023 Plan and the 2021 Employee Stock Purchase Plan (the “2021 ESPP”). EQUITY COMPENSATION PLAN INFORMATION

| Plan Category                                                 |     | Number of securities to  be issued upon exercise 
                          of outstanding options, 
                      warrants and rights (#) (a) |     | Weighted-average exercise  price of outstanding options, warrants and rights ($) (b) |     |                                            Number of securities 
 available for future  issuance under equity  compensation plans 
                                           (excluding securities 
                                 reflected in column (a) (#) (c) |
| Equity compensation plans approved by security holders        |     |                                    5,960,658 (1) |     |                                                                                 7.86 |     |                                                   3,910,177 (2) |
| Equity compensation plans not approved by security holders(3) |     |                                    1,829,000 (4) |     |                                                                                 5.26 |     |                                                       2,621,000 |
| Total                                                         |     |                                        7,789,658 |     |                                                                                      |     |                                                       6,531,177 |

| (1) | Includes (i) options to purchase a total of 100 shares of our common stock under the 2007 Plan, (ii) options to purchase a total of 4,651,300 shares of common stock under the 2014 Plan and (iii) 1,309,258 restricted stock units under our 2014 Plan. Restricted stock units do not have an exercise price and were not included in calculating weighted average exercise prices. |

| (2) | Consists of 2,762,165 shares of common stock reserved for issuance under the 2014 Plan and 1,148,012 shares of common stock reserved for issuance under the 2021 ESPP. The number of shares of our common stock reserved for issuance under the 2014 Plan will automatically increase each year on January